Win Much Larger Accounts. Produce Meaningful Alpha. Prevent and Reduce Serious Losses. Then, Charge Much Higher Fees. Exclusively with ERS's Data Science Technology.

No credit card required • Full platform access • Cancel anytime

Review Our 25-Year Benchmark Study Here

Our stock ratings have predicted performance with proven accuracy across 433,500+ data points over 25 years. No black boxes. No guesswork. Just quantitative science that works.

3 live portfolios created 12/31/25 Independently verified by BX Partners and IndexOne 25 years of backtested evidence
Year-to-Date Performance
Model Return Since 12/31/25 Freq. of Gains
Free Trial Resilient Value
Free Trial Resilient Income
Free Trial Small-Cap Growth
S&P 500

Return data as of previous trading day's close.

Download: 12 Critical Fiduciary Duties
Free Trial Portfolio Risk Analyzer™
Free Trial Active Risk Monitoring™

You Didn't Start a Firm to Be Ordinary

Every advisor faces a choice. The path you take today determines the firm you become tomorrow.

The Ordinary Path
Without Data Science
  • You compete on personality and promises
  • You hope the next downturn doesn't hit too hard
  • You tell prospects to trust you
  • You close clients who like you
  • You build a book of business
  • You react to market moves
  • You explain losses after the fact
  • When markets fall, you reassure and hope
  • Clients refer you because they like you
  • You wonder what you might be missing
  • Your firm's value depends on you
The Extraordinary Path
With Data Science
  • You compete with evidence and data
  • You use science to identify risks, then measure and rate them
  • You explain how data reveals clues to risks and potential
  • You close clients who understand and trust your methodology
  • You build not only an enterprise — you build a legacy
  • You monitor systematically and act on evidence
  • You document the disciplined process that guided every decision
  • When markets fall, you show the risks you identified and steps you took
  • Clients refer you because they're proud to be associated with your methodology
  • You sleep soundly knowing your system is watching
  • Your firm's value is built into the process itself

Both paths require hard work. Only one builds a legacy.

World-class means: Growing with confidence. Protecting with science. Explaining with patience. Building something that lasts beyond you — and that clients are proud to be part of.

Start Building Your Legacy
433,500
Ratings Validated
25
Years of Data
91%
Bankruptcies Flagged Early
21.4%
Enduring Portfolio Returns

How It Works

Three simple steps to smarter investing

📊
STEP 01

Check the Rating

Look up any stock and see its A+ through F rating
based on our proprietary Financial Strength Number™

📁
STEP 02

Build Your Portfolio

Choose from our ready-made models or
create your own using stocks rated B+ or higher

🔔
STEP 03

Monitor & Adjust

Active Risk Monitoring™ alerts you when any stock's
rating changes, so you're never caught off guard

The Proof Is in the Data

Our ratings aren't just theory — they're backed by 25 years of verifiable, independently auditable performance data.

Average 1-Year Return by FSN Grade

433,500 samples • Zero survivorship bias

+35% +25% +15% +5% 0%
+33.3%
+21.0%
+17.4%
+13.5%
+10.8%
+5.8%
-1.5%
-1.5%
A+
A
B
C
D
E
F

We welcome scrutiny. For institutional due diligence, we'll submit any 2 of our 9 proprietary ratings to independent third-party verification by McKinsey, PwC, or Deloitte — all under strict confidentiality agreements.

Ready-to-Use Model Portfolios

Don't want to pick individual stocks?
Our model portfolios are built using the same proven methodology.

Resilient Income

25-stock dividend-focused portfolio for steady income without sacrificing quality

Start Free Trial

Small-Cap Growth

11 high-potential smaller companies identified by our proprietary screening

Start Free Trial

Ready to Invest with Confidence?

Join advisors who've replaced guesswork with data-driven decisions.
Start your free trial today and see our methodology in action.

Verified by BX Partners
Independently Auditable
Zero Survivorship Bias